YOUCARE PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.01 CNY | +1.39% |
|
+15.18% | -23.25% |
| Apr. 09 | Youcare Pharma Gets Nod for Registration of Gastric Drug | MT |
| Feb. 23 | Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 4.2B 580M | Sales 2024 * | 4.46B 617M | Capitalization | 7.2B 996M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 2.24 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.61 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 3,188 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 44.06% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.39% | ||
| 1 week | +15.18% | ||
| Current month | -5.60% | ||
| 1 month | -5.60% | ||
| 3 months | -4.13% | ||
| 6 months | -14.06% | ||
| Current year | -23.25% |
1 week
13.91
16.20
1 month
13.3017.33
Current year
11.9921.18
1 year
11.9927.88
3 years
11.9933.37
5 years
11.9936.66
10 years
11.9936.66
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Shi Yu
FOU | Founder | 78 | 01-08-13 |
Fei Yu
CEO | Chief Executive Officer | 35 | 11-12-31 |
Yan Liu
DFI | Director of Finance/CFO | 52 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bo Wang
BRD | Director/Board Member | 64 | 19-05-14 |
Hua Cheng
BRD | Director/Board Member | 44 | 19-05-14 |
Ke Ji Chen
BRD | Director/Board Member | 94 | 19-05-14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 16.01 | +1.39% | 3,700,703 |
| 24-04-26 | 15.79 | +1.54% | 2,947,223 |
| 24-04-25 | 15.55 | +3.74% | 5,562,821 |
| 24-04-24 | 14.99 | +5.79% | 6,040,230 |
| 24-04-23 | 14.17 | +1.94% | 3,523,676 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotes
Youcare Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the development and production of chemical drugs. The Companyâs products are mainly cardiovascular and cerebrovascular drugs, digestive system drugs, diabetes drugs and anti-infective drugs, including ginkgo biloba extract injection, gastrodin injection, lansoprazole for injection, and omeprazole enteric-coated capsules , metformin hydrochloride sustained-release tablets, cefuroxime sodium for injection and ceftriaxone sodium for injection, etc. The Company conducts its businesses within the China market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.01
CNY
Average target price
28
CNY
Spread / Average Target
+74.89%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.25% | 981M | |
| +4.06% | 70.44B | |
| +12.15% | 8.94B | |
| -14.44% | 4.75B | |
| +41.60% | 4.5B | |
| +5.96% | 3.85B | |
| +23.46% | 2.38B | |
| -19.32% | 2.34B | |
| -27.04% | 2.2B | |
| +7.97% | 1.96B |
- Stock Market
- Equities
- 688658 Stock
